When a clinician encounters a patient with a pathogenic and damaging ARMC5 variant, screening for Cushing syndrome and primary aldosteronism is encouraged. This evidence concerns the gene ARMC5 and Cushing syndrome due to macronodular adrenal hyperplasia.